A large study published in medical journal “The Lancet” indicated that malaria drug, hydroxy chloroquine, which US President Donald Trump says he is taking and urging ors to use, is linked to an increased risk of dying of Corona patients, whose condition requires hospitalization.
In study, which examined more than 96,000 cases of coronaviruses in hospitals, it was found that those treated with hydroxychloroquine or chloroquine were more likely to die than those who were not treated with m.
The study’s authors said y could not confirm if this drug had any benefit against SK.
“Rapid confirmation from randomized clinical trials is needed,” y wrote.
The study did not include experiments controlled with drug use and comparison with placebo.
The infection of those hospitalized is usually more severe than ors. Some proponents of two drugs say that y may need to be used at an early stage to be effective.
The demand for hydroxychloroquine, a decadesold treatment with Trump’s repeated pressure to use it to treat virus, has increased and his demand for people to try it. He said: “You will not lose anything.”
Trump said this week that he was using hydroxychloroquine for prevention, despite lack of scientific evidence.
The authors of study, published in The Lancet, suggested that two drugs avoid treatment in nonclinical trials, until studies confirm ir safety and efficacy against corona.
The US Food and Drug Administration said that hydroxychloroquine should only be used in hospital patients or in clinical trials.
The study looked at data of 671 hospitals. 14,888 patients were given eir hydroxychloroquine or chloroquine, with or without an antibiotic, and 81,144 patients were not treated with se drugs.
Hydroxychloroquine and chloroquine showed evidence of efficacy against virus in laboratory, but studies of two treatments in patients demonstrated that y were inconclusive at best.